A Quality Manager’s Perspective of AI Agency Risk Artificial intelligence (AI) is moving rapidly from passive assistance to active participation in regulated processes. Many organisations are comfortable deploying AI as a static tool; for example, to help draft documents, search standard operating procedures (SOPs), or summarise information. In these cases, existing quality and validation approaches…
Balancing innovation with regulatory expectations Artificial Intelligence (AI) is revolutionising pharmaceutical manufacturing, enabling predictive analytics, automated quality checks, and real-time decision-making. While these advancements promise efficiency and accuracy, they also introduce new challenges for data integrity—a cornerstone of Good Manufacturing Practice (GMP) and therapeutic product manufacturers must ensure compliance when leveraging AI-driven systems. AI in…
As pharmaceutical manufacturing embraces digitalisation and connectivity, cybersecurity has become a critical component of Good Manufacturing Practice (GMP). Networked systems enable efficiency and real-time data exchange, but they also introduce vulnerabilities that can compromise data integrity and product quality. This blog explores common cybersecurity risks in GMP environments, advanced mitigation strategies, and practical steps for…
When budgeting for personnel to attend conferences and networking events, decision-makers often prioritise costs and potential downtime over the long-term benefits. However, investing in professional development (PD) opportunities for life science professionals can lead to significant productivity gains and financial returns. Professional Development is best viewed as an ‘uptime’ opportunity vs a ‘downtime’ event. That’s…
The time has come for us to talk about the Data Integrity elephant in the GMP room. Despite Data Integrity being a hot topic in industry for the past 5 years, it continues to attract a lot of attention – the constant discussion generating more questions than answers, and creating confusion over what does and…
Electronic signatures (E-signatures) are becoming more and more commonly used in today’s world. Before electronic signatures were recognized and accepted legally, documents had to be manually signed by each of the signatories, stored and filed in squeaky compactors (compactus to some) held within a rather dark records room. Obviously, this process is very time consuming…
GMP Basics of Good Documentation Practices (GDocP) Good Documentation Practice is a crucial component of regulatory compliance, including data integrity assurances. Referred to in the industry as Good Documentation Practice (GDocP/GDP) and/or Good Recordkeeping Practice (GRK), the term generally involves ensuring data integrity by adhering to ALCOA ++ principles. GRK/GDocP is mandatory to ensure that…
Yes, we are still talking about the very old issue of Good Manufacturing Practice Pens or GMP pens and the most suitable colour of ink for pharmaceutical manufacturing pens and other issues. The various codes simply refer to “indelible ink”, as snipped from PIC/S Version 13 Good Manufacturing Practices, §4.7 Good Documentation Practices 4.7 Handwritten…
Please complete the form on the PharmOut contact us page. We will get back to you within one business day.
Phone: +61 3 9887 6412
Email: info@pharmout.net
